Knock Down of HMGA2 Suppresses Colorectal Cancer Progression through Inhibiting Angiogenesis via Compromising VEGFR2 Signaling in HUVECs
نویسندگان
چکیده
Colorectal cancer is one of the major public health issues worldwide due to its high mortality and morbidity. Angiogenesis fundamental step tumors transition from dormant malignant state it recognized as hallmarks cancer. High mobility group AT-hook 2 encodes a small non-histone chromatinassociated protein that can modulate transcription by altering chromatin architecture. Currently mechanism which involved in angiogenesis colorectal has not been clarified. The expression was analyzed immunohistochemistry, Western blotting bioinformatics methods. cBioPortal mExpress online tools were applied explore copy-number variation methylation patients. Single cell data gene omnibus used examine specific type contributed Lentivirus knock down cells human umbilical vein endothelial study angiogenesis. In current study, we first detected pattern patients evaluated clinical values for time showed copy number amplification up regulation By analyzing single found specifically regulated epithelial cells. Furthermore, knocking suppresses via dual vascular growth factor-A semaphorin 3A through inactivating factor receptor pathway might be promising prognostic marker target treating advanced
منابع مشابه
DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling
As angiogenesis is required for tumor growth and metastasis, suppressing angiogenesis is a promising strategy in limiting tumor progression. Vascular endothelial growth factor (VEGF)-A, a critical pro-angiogenic factor, has thus become an attractive target for therapeutic interventions in cancer. In this study, we explored the underlying mechanisms of a novel anthraquinone derivative DDA in sup...
متن کاملQuinazoline derivative compound (11d) as a novel angiogenesis inhibitor inhibiting VEGFR2 and blocking VEGFR2-mediated Akt/mTOR /p70s6k signaling pathway
Objective(s): We previously reported a series of quinazoline derivatives as vascular-targeting anticancer agents. In this study, we investigated the mechanism underlying the anti-angiogenic activity of the quinazoline derivative compound 11d. Materials and Methods: We examined the effects of quinazoline derivative 11d on vascular endothelial growth factor receptor-2 (VEGFR2) activation via VEG...
متن کاملRRS1 silencing suppresses colorectal cancer cell proliferation and tumorigenesis by inhibiting G2/M progression and angiogenesis
Colorectal cancer (CRC) is one of the most common malignancies worldwide. Ribosome biogenesis regulatory protein homolog (RRS1) is an essential factor involved in ribosome biogenesis, while its role in CRC remains largely unclear. Here, we found that RRS1 expression was significantly higher in CRC tissues compared with adjacent normal tissues. RRS1 High expression also predicted poor overall su...
متن کاملquinazoline derivative compound (11d) as a novel angiogenesis inhibitor inhibiting vegfr2 and blocking vegfr2-mediated akt/mtor /p70s6k signaling pathway
objective(s): we previously reported a series of quinazoline derivatives as vascular-targeting anticancer agents. in this study, we investigated the mechanism underlying the anti-angiogenic activity of the quinazoline derivative compound 11d. materials and methods: we examined the effects of quinazoline derivative 11d on vascular endothelial growth factor receptor-2 (vegfr2) activation via vegf...
متن کاملBerberine suppresses migration of MCF-7 breast cancer cells through down-regulation of chemokine receptors
Objective(s): Berberine is one of the main alkaloids and it has been proven to have different pharmacological effects including inhibition of cell cycle and progression of apoptosis in various cancerous cells; however, its effects on cancer metastasis are not well known. Cancer cells obtain the ability to change their chemokine system and convert into metastatic cells. In this study, we examine...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Pharmaceutical Sciences
سال: 2023
ISSN: ['0250-474X', '1998-3743']
DOI: https://doi.org/10.36468/pharmaceutical-sciences.spl.620